tradingkey.logo

NewGenIvf Group Ltd

NIVF
查看详细走势图
1.000USD
0.0000.00%
收盘 02/06, 16:00美东报价延迟15分钟
143.51K总市值
0.00市盈率 TTM

NewGenIvf Group Ltd

1.000
0.0000.00%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

0.00%

5天

-27.01%

1月

-47.09%

6月

-89.30%

今年开始到现在

-51.69%

1年

-99.85%

查看详细走势图

TradingKey NewGenIvf Group Ltd股票评分

单位: USD 更新时间: 2026-02-06

操作建议

NewGenIvf Group Ltd当前公司基本面数据相对稳定,最新ESG披露属于行业领先水平。增长潜力较大。当前估值低估,在医疗服务供应商行业排名69/75位。机构持股占比低,近一月多位分析师给出公司评级为。最高目标价225.00。中期看,股价处于下降通道。

NewGenIvf Group Ltd评分

相关信息

行业排名
69 / 75
全市场排名
541 / 4521
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

NewGenIvf Group Ltd亮点

亮点风险
NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
业绩增长期
公司处于发展阶段,最新年度总收入5.43M美元
业绩转亏
公司业绩转亏,最新年度亏损美元
估值合理
公司最新PE估值0.00,处于3年历史合理位
机构加仓
最新机构持股1.53K股,环比增加43.38%

分析师目标

根据 0 位分析师
--
评级
225.000
目标均价
+22400.00%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

NewGenIvf Group Ltd新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

NewGenIvf Group Ltd简介

NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
公司代码NIVF
公司NewGenIvf Group Ltd
CEOWing Fung (Siu)
网址https://newgenivf.com/
KeyAI